Document is current
Any future updates will be listed below
-
Authors
Arens, Stefan https://orcid.org/0000-0003-0836-379X
Sustar, Ursa
Lange, Karin
Danne, Thomas
Battelino, Tadej
Groselj, Urh
Kordonouri, Olga
-
Funding
Funding for this research was provided by:
Sanofi-Aventis Deutschland
Slovenian Research and Innovation Agency Program (# P3-0343)
Slovenian Research and Innovation Agency Program (# P3-0343)
Slovenian Research and Innovation Agency Program (# P3-0343)
Juvenile Diabetes Research Foundation (2-SRA-2016-243-Q-R)
Juvenile Diabetes Research Foundation (2-SRA-2016-243-Q-R)
Juvenile Diabetes Research Foundation (2-SRA-2016-243-Q-R)
Liona M. and Harry B. Helmsley Charitable Trust
- License Information
-
More Information
Article History
Received: 14 May 2026
Accepted: 31 August 2026
First Online: 4 September 2026
Declarations
Ethics approval and consent to participate: Informed consent was obtained from at least one parent or guardian. All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Hannover Medical School, Germany (MHH, Number of Approval 7089/20.01.2016 and 27.09.2018) and with the Helsinki declaration and its latest revisions or comparable ethical standards.
Competing interests: S.A.: Speaker’s honoraria from Daiichi-Sankyo and Infectopharm.U.S.: no conflict of interest related to the topic of this manuscript.K.L.: no conflict of interest related to the topic of this manuscript.T.D.: Thomas Danne has received speaker’s honoraria and research support from or has consulted for Abbott, AstraZeneca, Boehringer, DexCom, Lilly, Medtronic, Novo Nordisk, Provention Bio, Roche, Sanofi and Vertex and is a shareholder of DreaMed Ltd.T.B.: no conflict of interest related to the topic of this manuscript. U.G.: no conflict of interest related to the topic of this manuscript. O.K.: Honoraria from Daiichi-Sankyo and Sanofi.
